Derace L. Schaffer, Director at Altimmune, Inc. (ALT), bought 21,808 shares at $2.10 ($44K) on 2017-11-22, disclosed to the SEC on 2017-11-27.
Open-market purchase of $44k ALT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.10 | 5,261 | $11K | 25.0% |
| 2 | $2.02 | 6,505 | $13K | 29.7% |
| 3 | $2.00 | 10,042 | $20K | 45.4% |
| Total | $2.03 avg | 21,808 | $44K | 100% |
| Filing → |
| LNTH | SELL | 2019-04-03 | $244K | — | Filing → |
| ALT | BUY | 2018-01-02 | $375K | — | Filing → |
| ALT | BUY | 2017-12-27 | $352K | — | Filing → |